An Open, Single Center, Randomized Controlled Clinical Study of UCB (Cord Blood) in the Treatment of Newly Diagnosed Acute Myeloid Leukemia (AML)
Clinical trial NCT05577611 · UNKNOWN
Trial details
- NCT number
- NCT05577611
- Sponsor
- Zhongnan Hospital
- Status
- UNKNOWN
- Phase
- Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2022-08-10
- Primary completion
- 2024-12-25
- Enrollment
- 57
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.